XENE icon

Xenon Pharmaceuticals
XENE

Overview Fund Activity

206 hedge funds and large institutions have $2.58B invested in Xenon Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 68 increasing their positions, 73 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
206
Holders Change
-3
Holders Change %
-1.44%
% of All Funds
2.8%
Holding in Top 10
14
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.69%
% of All Funds
0.19%
New
20
Increased
68
Reduced
73
Closed
23
Calls
$14.8M
Puts
$6.93M
Net Calls
+$7.9M
Net Calls Change
+$3.62M

Top Buyers

1
DTC
Deep Track Capital
Connecticut
+$27.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$25.6M
3
LGM
Logos Global Management
California
+$21.8M
4
Capital International Investors
Capital International Investors
California
+$18.2M
5
VPC
Vestal Point Capital
New York
+$16.4M

Top Sellers

1
BBA
Baker Bros. Advisors
New York
-$21.7M
2
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$21.5M
3
FLAM
First Light Asset Management
Minnesota
-$17.9M
4
CC
Commodore Capital
New York
-$13.9M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$10.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
VEA
226
Virtus ETF Advisers
New York
– -$70.6K -1,802 Closed
QCG
227
Quadrant Capital Group
Ohio
– -$2.59K -66 Closed
CMBA
228
C.M. Bidwell & Associates
Hawaii
– -$353 -9 Closed
HCP
229
Hexagon Capital Partners
Arkansas
– -$235 -6 Closed
6 7 8 9
10